The question is no longer if obesity pharmacotherapy will transform obesity management, but how fast and how far it will go
Zepbound carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The medications often carry monthly costs approaching or exceeding $1,000 without insurance coverage, and many insurance plans require prior authorization or limit coverage to patients with diabetes rather than obesity alone
With locations in Beverly Hills, Burbank, Glendale, Granada Hills, and Santa Clarita, our staff of highly-qualified nurses is experienced in the latest laser technology and injection procedures
Without insurance, you might pay between $800 and $1,500 per month, for the brand name Wegovy or Ozempic